Présentation de l'entreprise
Horizon Technology Finance Corporation operates as a specialized business development company dedicated to providing secured debt and venture lending investments to development-stage companies within the technology, life science, and healthcare information sectors. Although the specific sector and industry classifications are not explicitly defined in the available data, the entity functions within the realm of alternative lending and venture capital-backed financing, targeting companies that have received backing from venture capital firms. The company's scale is quantified by a market capitalization that is currently unavailable, an annual revenue of $108.44 million, and an employee count that remains unlisted. These financial figures, particularly the revenue stream, indicate that the organization maintains a significant operational footprint within its niche, generating substantial income despite the lack of public data regarding its total number of employees or exact market valuation.
Santé financière
Horizon Technology Finance Corporation reported a trailing twelve-month revenue of $108.44 million against a net income loss of $2,505,000, while EBITDA data is not provided in the current records. The substantial disparity between the high revenue figure and the negative net income reveals a cost structure where operating expenses or interest costs exceed the bottom-line earnings, a characteristic often seen in high-growth or early-stage lending models. Despite the net loss, the company generated positive free cash flow of $34.32 million, which underscores a strong capacity for financial flexibility and the ability to fund operations or repay obligations without relying solely on external equity financing. The company maintains a cash reserve of $34.82 million, which is slightly higher than its total debt load of $435.50 million, although the debt-to-equity ratio stands at 125.66, indicating a highly leveraged balance sheet typical for business development companies. The current ratio of 3.41 suggests robust short-term liquidity, as the company holds significantly more current assets than current liabilities, ensuring it can meet its immediate financial obligations with ease. Management effectiveness is further scrutinized through return metrics, where the return on equity is -0.8% reflecting the net loss impact, whereas the return on assets stands at 7.2%, indicating that the asset base is generating positive returns before the dilution effect of the equity structure or interest expenses.
Évaluation de la valorisation
The trailing twelve-month price-to-earnings ratio is 21.01, while the forward P/E ratio is unavailable, suggesting that market expectations for future earnings growth or stability are not yet quantified through a forward multiple. The price-to-book ratio is 2.47, which implies that the market values the company's equity at a significant premium over its accounting book value, likely reflecting the perceived value of its loan portfolio or intangible assets not fully captured on the balance sheet. Alternative valuation metrics such as the price-to-sales ratio and EV/EBITDA are not available in the provided data, limiting the ability to compare the company's valuation against peer benchmarks using these specific multiples. The stock has traded between a 52-week low of $24.60 and a 52-week high of $26.61, placing the current trading price within a relatively narrow historical range that suggests low volatility in the short term. The beta of 1.17 indicates that the stock's price volatility is slightly higher than that of the broader market, meaning the stock tends to move more aggressively than the general market index during periods of price fluctuation.
Growth & Income
Horizon Technology Finance Corporation experienced a year-over-year revenue growth of 25.3%, while the earnings growth rate is not available due to the recent net loss position. The absence of earnings growth data, coupled with the revenue expansion, implies that the company is prioritizing top-line expansion through increased lending volumes over immediate profitability, a common strategy for development-stage finance entities. The company does not currently pay a dividend, evidenced by the unavailable dividend yield and payout ratio, which means that all available earnings are retained within the company to fund growth initiatives and strengthen the capital base. Consequently, the overall growth and income profile is characterized by capital appreciation potential rather than income generation, as the company reinvests its resources into expanding its portfolio of technology and life science investments.